Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients.
about
Mineral and bone disorder after kidney transplantationImprovement of fatigue after vitamin D supplementation in kidney transplant recipients.Impact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patientsDiabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation.Nutritional Vitamin D in Renal Transplant Patients: Speculations and Reality.1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure.Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells.More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients.The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.Phosphate and FGF-23 homeostasis after kidney transplantation.Design and implementation of a custom next generation sequencing panel for selected vitamin D associated genesSerum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.Current evidence on vitamin D deficiency and kidney transplant: What's new?CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health.Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion.Vitamin D status in renal transplant recipients living in a low-latitude city: association with body fat, cardiovascular risk factors, estimated glomerular filtration rate and proteinuria.Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients.
P2860
Q26771398-90A27FE3-8A75-4E3B-8C7D-9E08D9F37A0FQ33760516-046FACD3-1FE0-405B-AEFA-8EEC5B31E263Q33783035-83549AA5-2E1E-43DC-B882-E5F8FD217298Q33802182-1476FF53-B998-41A2-9C09-A88DD959E08BQ33851824-E9CCB47B-349C-4081-ABB4-31B558469F23Q35755817-35330D3F-10D7-4771-ADB0-9B34B1119BCCQ36293005-CD502769-3A8E-4CE1-9D2D-5E67F1785A2FQ37522572-5157A9F8-E8D2-4BE6-8B59-A42A35A5B372Q38496715-BF83B503-E7EC-4AFD-AA67-414FF30BBDE3Q38594874-FCAEF212-CFB8-4A86-99D4-EC839EED2974Q38654731-B9327B78-3871-4FF5-B8DC-B77BC4BCBEE3Q38745657-F61CB53E-CA5D-4165-94C6-FF8EC01519B1Q38762820-A46A6FD7-BF4C-453C-B59E-B39726FCA2D2Q38803449-505E2A26-7848-45AD-8E4D-036984102599Q39172404-72AAA580-A619-470C-9E34-C6DAAB73038AQ39247900-CC6984AC-838E-4122-8F49-1D7E8738EBAEQ39447041-F72DFBB2-D4E4-4C23-8696-42618A2C5423Q40168487-8D0E660B-986E-41AE-946D-D109648CD29BQ49449891-3DB4859A-B77A-45F5-A4B3-B6689EB01CBE
P2860
Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Associations of 25(OH) and 1,2 ...... e renal transplant recipients.
@en
Associations of 25(OH) and 1,2 ...... e renal transplant recipients.
@nl
type
label
Associations of 25(OH) and 1,2 ...... e renal transplant recipients.
@en
Associations of 25(OH) and 1,2 ...... e renal transplant recipients.
@nl
prefLabel
Associations of 25(OH) and 1,2 ...... e renal transplant recipients.
@en
Associations of 25(OH) and 1,2 ...... e renal transplant recipients.
@nl
P2093
P356
P1476
Associations of 25(OH) and 1,2 ...... e renal transplant recipients.
@en
P2093
Anna C Muller Kobold
Charlotte A Keyzer
Gerjan Navis
Ido P Kema
Ineke J Riphagen
Martin H de Borst
Michel M Joosten
NIGRAM consortium
Stephan J L Bakker
P356
10.1210/JC.2014-3012
P407
P577
2015-01-01T00:00:00Z